Charles River Laboratories International, Inc. Stock
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
229 USD | +0.54% | -1.52% | -3.12% |
Financials (USD)
Sales 2024 * | 4.22B | Sales 2025 * | 4.54B | Capitalization | 11.7B |
---|---|---|---|---|---|
Net income 2024 * | 420M | Net income 2025 * | 525M | EV / Sales 2024 * | 3.24 x |
Net Debt 2024 * | 1.98B | Net Debt 2025 * | 1.51B | EV / Sales 2025 * | 2.91 x |
P/E ratio 2024 * |
28.1
x | P/E ratio 2025 * |
22.9
x | Employees | 21,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.19% |
Latest transcript on Charles River Laboratories International, Inc.
1 day | +0.54% | ||
1 week | -1.52% | ||
Current month | -15.47% | ||
1 month | -14.98% | ||
3 months | +1.99% | ||
6 months | +32.70% | ||
Current year | -3.12% |
Managers | Title | Age | Since |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 75-12-31 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 22-04-24 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 89-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
C. Reese
BRD | Director/Board Member | 78 | 07-12-02 |
George Massaro
BRD | Director/Board Member | 76 | 02-12-31 |
Virginia Wilson
BRD | Director/Board Member | 68 | 19-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.05% | 1 M€ | 0.00% | - | |
2.07% | 5 M€ | -1.80% | - | |
1.08% | 0 M€ | 0.00% | - | |
0.98% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 227.8 | -4.85% | 762,872 |
24-04-24 | 239.4 | -0.29% | 705,117 |
24-04-23 | 240.1 | +3.26% | 611,881 |
24-04-22 | 232.6 | +2.55% | 544,691 |
24-04-19 | 226.8 | -0.34% | 409,097 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.12% | 11.7B | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
+6.35% | 11.1B | |
-16.98% | 9.85B |
- Stock Market
- Equities
- CRL Stock